Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Life Sciences|January 1, 1994
Imaging, biodistribution and therapy potential of halogenated tamoxifen analoguesD J Yang, C Li, L R Kuang, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|January 7, 2017
[Molecular epidemiology of Japanese encephalitis viruses isolated in Yunnan province, 1977-2010]Y Feng, H L Zhang, W H Yang, et al.
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1988
NMDA receptor channels: labeling of MK-801 with iodine-125 and fluorine-18D M Wieland, M R Kilbourn, D J Yang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancerP Bassa, E E Kim, T Inoue, et al.
European Journal of Nuclear Medicine|October 1, 1996
Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinomaS H Yeh, R S Liu, L C Wu, et al.
Pharmaceutical Research|February 1, 1991
Synthesis and in vitro receptor binding studies of fluorotamoxifen analoguesD J Yang, S Wallace, W Tansey, et al.
Journal of Drug Targeting|January 1, 1996
Development of new markers for hypoxic cells: [131I]Iodomisonidazole and [131I]IodoerythronitroimidazoleA Cherif, S Wallace, D J Yang, et al.
Journal of Pharmaceutical Sciences|March 1, 1996
Assessment of tumor cell proliferation using [18F]fluorodeoxyadenosine and[18F]fluoroethyluracilC G Kim, D J Yang, E E Kim, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 11, 1992
Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PETE E Kim, S K Chung, T P Haynie, et al.
Pageof 11